Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study

J Am Acad Dermatol. 2019 Sep;81(3):859-860. doi: 10.1016/j.jaad.2019.04.068. Epub 2019 May 11.

Authors

Cristian D Gonzalez¹, Christopher Hansen¹, Jennie T Clarke²

Affiliations

¹ Department of Dermatology, University of Utah, Salt Lake City, Utah.
² Department of Dermatology, University of Utah, Salt Lake City, Utah. Electronic address: [email protected].

PMID: 31085265
DOI: 10.1016/j.jaad.2019.04.068

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Antimalarials / adverse effects*
Dermatomyositis / drug therapy*
Drug Eruptions / diagnosis
Drug Eruptions / epidemiology*
Drug Eruptions / etiology
Female
Follow-Up Studies
Humans
Hydroxychloroquine / adverse effects
Incidence
Lupus Erythematosus, Cutaneous / drug therapy*
Male
Middle Aged
Retrospective Studies
Severity of Illness Index
Young Adult

Substances

Antimalarials
Hydroxychloroquine